Quoin Pharmaceuticals (QNRX) Change in Cash (2021 - 2026)

Quoin Pharmaceuticals has reported Change in Cash for 6 years, with the latest figure at -$693573.0 in Q1 2026.

• Quarterly Change in Cash fell 448.92% year-over-year to -$693573.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$697599.0 (down 135.08% YoY) and the FY2025 annual result came in at $194753.0, down 84.06% from the prior year.
• Change in Cash retreated to -$693573.0 in Q1 2026 per QNRX's latest filing, from $2.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $2.6 million in Q3 2022 and troughed at -$2.5 million in Q2 2022.
• A 5-year average of -$256367.6 and a median of $162414.0 in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2026: Change in Cash surged 339.93% in 2022, then slumped 448.92% in 2026.
• Over 5 years, Change in Cash stood at -$2.4 million in 2022, then surged by 68.1% to -$762228.0 in 2023, then surged by 166.46% to $506593.0 in 2024, then jumped by 292.27% to $2.0 million in 2025, then sank by 134.9% to -$693573.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$693573.0, $2.0 million, and $162414.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.